Swiss Life Asset Management’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.1M | Buy |
187,183
+10,343
| +6% | +$1.19M | 0.09% | 175 |
|
|
2026
Q1 | $21.1M | Buy |
176,840
+20,816
| +13% | +$2.73M | 0.1% | 159 |
|
|
2025
Q4 | $21.2M | Buy |
156,024
+16,292
| +12% | +$2.34M | 0.11% | 152 |
|
|
2025
Q3 | $20.6M | Buy |
139,732
+9,800
| +8% | +$1.36M | 0.11% | 149 |
|
|
2025
Q2 | $16.8M | Buy |
129,932
+16,953
| +15% | +$2.05M | 0.1% | 162 |
|
|
2025
Q1 | $13.5M | Buy |
112,979
+4,872
| +5% | +$604K | 0.1% | 164 |
|
|
2024
Q4 | $12.5M | Buy |
108,107
+15,863
| +17% | +$2.01M | 0.09% | 164 |
|
|
2024
Q3 | $12.4M | Buy |
92,244
+1,427
| +2% | +$191K | 0.14% | 138 |
|
|
2024
Q2 | $12.3M | Buy |
90,817
+81,904
| +919% | +$11.1M | 0.15% | 133 |
|
|
2024
Q1 | $1.15M | Sell |
8,913
-121,599
| -93% | -$14.7M | 0.02% | 403 |
|
|
2023
Q4 | $14.9M | Buy |
130,512
+12,501
| +11% | +$1.25M | 0.18% | 124 |
|
|
2023
Q3 | $10.7M | Sell |
118,011
-69,866
| -37% | -$7.21M | 0.17% | 146 |
|
|
2023
Q2 | $21.2M | Buy |
187,877
+100,173
| +114% | +$10.6M | 0.31% | 61 |
|
|
2023
Q1 | $9.18M | Buy |
87,704
+53,324
| +155% | +$5.57M | 0.14% | 190 |
|
|
2022
Q4 | $3.81M | Sell |
34,380
-59,535
| -63% | -$6.24M | 0.06% | 316 |
|
|
2022
Q3 | $8.2M | Buy |
93,915
+6,968
| +8% | +$633K | 0.14% | 179 |
|
|
2022
Q2 | $6.81M | Buy |
86,947
+46,782
| +116% | +$3.86M | 0.11% | 212 |
|
|
2022
Q1 | $3.42M | Buy |
40,165
+27,459
| +216% | +$2.63M | 0.05% | 354 |
|
|
2021
Q4 | $1.53M | Sell |
12,706
-7,745
| -38% | -$961K | 0.02% | 444 |
|
|
2021
Q3 | $2.53M | Buy |
+20,451
| New | +$2.63M | 0.04% | 397 |
|
|
2018
Q4 | – | Sell |
-24,234
| Closed | -$1.94M | – | 477 |
|
|
2018
Q3 | $1.94M | Buy |
+24,234
| New | +$1.81M | 0.03% | 325 |
|
|
2018
Q2 | – | Sell |
-7,342
| Closed | -$565K | – | 564 |
|
|
2018
Q1 | $565K | Sell |
7,342
-10,596
| -59% | -$783K | 0.01% | 408 |
|
|
2017
Q4 | $1.22M | Sell |
17,938
-2,659
| -13% | -$177K | 0.03% | 316 |
|
|
2017
Q3 | $1.29M | Buy |
20,597
+907
| +5% | +$54.2K | 0.03% | 274 |
|
|
2017
Q2 | $1.09M | Buy |
19,690
+1,780
| +10% | +$92.7K | 0.03% | 309 |
|
|
2017
Q1 | $900K | Buy |
+17,910
| New | +$873K | 0.02% | 312 |
|
|
2016
Q3 | – | Sell |
-27,238
| Closed | -$1.21M | – | 448 |
|
|
2016
Q2 | $1.21M | Buy |
+27,238
| New | +$1.18M | 0.05% | 161 |
|
Other funds holding XYL
Swiss Life Asset Management's XYL Position: Q2 2026 in Review
Swiss Life Asset Management increased its Xylem (XYL) stake by 5.8% in Q2 2026, buying an estimated $1.19M and bringing the position to 187,183 shares worth $22.1M. The position accounts for 0.09% of the portfolio, ranked #175.
Swiss Life Asset Management first reported a position in XYL in Q2 2016 and has held it in 27 quarters since. 744 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Swiss Life Asset Management held 187,183 shares of Xylem worth $22.1M as of Q2 2026.
- Swiss Life Asset Management bought 10,343 Xylem shares in Q2 2026, an estimated $1.19M.
- Xylem made up 0.09% of Swiss Life Asset Management's portfolio in Q2 2026, its #175 holding.
- Swiss Life Asset Management first reported a position in Xylem in Q2 2016 and has held it in 27 quarters since.
- 744 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.